DUBLIN, May 19, 2015 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/4983bk/mycoplasma) has announced the addition of the "Mycoplasma Testing Market by Products, Application, Technology, End User - Global Forecast to 2019" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The global mycoplasma testing market is expected to reach $613.49 Million by 2019 from $340.29 Million in 2014, growing at a CAGR of 12.51% between 2014 and 2019
Mycoplasma testing market refers to a wide range of assays and services aimed at ensuring the quality and purity of products and raw materials used in the production of biologics for the pharmaceutical and biotech industries. Spending on R&D in life science research and growing biotechnology & pharmaceutical companies for life science research will drive the growth of this market.
This report segments the global mycoplasma testing market by products, technology, applications and end users. The global market product segments included in the report comprises of instruments, kits & reagents and services. The kits & reagents segment is further divided on the basis of type into stains, elimination kits, PCR assays, nucleic acid detection kits, standards & controls and other kits & reagents.
The technology segments included in the report includes microbial culture techniques, DNA staining, PCR, ELISA, direct assay, indirect assay and enzymatic methods. The applications included in this report are cell line testing, virus testing, end of production cells testing and other applications. The cell line testing applications had the largest share of the mycoplasma testing market in 2014. The cell line testing applications are expected to one of the fastest growing applications between 2014 and 2019.
On the basis of end users the global market report is segmented into biotechnology and pharmaceutical companies, academic research institutes, cell banks, contract research organizations and other end users.
The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global mycoplasma testing market in 2014. Asia regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increase in biopharmaceutical companies and spending on R&D in life science research from this region.
The major players in mycoplasma testing market include Merck KGaA (U.S.), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), Lonza Group Ltd. (Switzerland), Charles River Laboratories International, Inc. (U.S.), Promo Cell GmbH (Germany), Bionique Testing Laboratories, Inc.(France), American Type Culture Collection (U.S.), InvivoGen.(U.S.), Biological Industries Israel Beit Haemek Ltd. (Israel) and others.
For more information visit http://www.researchandmarkets.com/research/4983bk/mycoplasma
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets